Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gout drug shows promise for diabetic kidney protection

NCT ID NCT07177898

First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 28 times

Summary

This study looked at whether adding allopurinol (a gout medication) to lisinopril (a blood pressure drug) could better protect kidneys in 80 adults with type 2 diabetes and normal uric acid levels. Participants were split into two groups: one received both drugs, the other lisinopril alone. Researchers tracked kidney function over a year. The goal was to see if the combination slowed kidney damage better than lisinopril alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE (DKD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • King Edward Medical University

    Lahore, Punjab Province, 54000, Pakistan

Conditions

Explore the condition pages connected to this study.